# Detomidine.
**AGENCY:**
Food and Drug Administration, HHS.
**ACTION:**
Correcting amendment.
**SUMMARY:**
The Food and Drug Administration (FDA) published a document in the *Federal Register* of April 23, 2010 (75 FR 21162), that amended the animal drug regulations to reflect approval of an original new animal drug application (NADA). FDA is correcting a paragraph describing limitations to the approved conditions of use for detomidine hydrochloride oromucosal gel in horses. This correction is being made to improve the accuracy of the animal drug regulations.
**DATES:**
This rule is effective March 24, 2011.
**FOR FURTHER INFORMATION CONTACT:**
George K. Haibel, Center for Veterinary Medicine (HFV-6), Food and Drug Administration, 7519 Standish Pl., Rockville, MD 20855, 240-276-9019, e-mail: *[email protected].*
**SUPPLEMENTARY INFORMATION:**
FDA published a document in the *Federal Register* of April 23, 2010 (75 FR 21162), that amended the animal drug regulations to reflect approval of an original NADA. FDA is correcting a paragraph describing limitations to the approved conditions of use for detomidine hydrochloride oromucosal gel in horses. This correction is being made to improve the accuracy of the animal drug regulations.
**List of Subjects in 21 CFR Part 529**
Animal drugs.
Accordingly, 21 CFR part 529 is corrected by making the following correcting amendment:
**21 CFR Part 529**
**PART 529—CERTAIN OTHER DOSAGE FORM NEW ANIMAL DRUGS**
1. The authority citation for part 529 continues to read as follows:
**Authority:**
21 U.S.C. 360b.
**21 CFR Part 529**
2. In § 529.536, amend paragraph (c)(3) by adding a sentence after the first sentence to read as follows:
§ 529.536
(c) * * *
(3) * * * Do not use in horses intended for human consumption.
Dated: March 17, 2011.
Leslie Kux,
Acting Assistant Commissioner for Policy.